Financials Yunnan Botanee Bio-Technology Group Co.LTD

Equities

300957

CNE100004G74

Personal Products

End-of-day quote Shenzhen S.E. 18:00:00 2024-07-15 EDT 5-day change 1st Jan Change
46.88 CNY +1.27% Intraday chart for Yunnan Botanee Bio-Technology Group Co.LTD +7.11% -31.23%

Valuation

Fiscal Period: December 2021 2022 2023 2024 2025 2026
Capitalization 1 81,450 63,218 28,877 19,718 - -
Enterprise Value (EV) 1 79,464 60,766 26,936 17,399 16,939 16,233
P/E ratio 90.7 x 60.2 x 38.1 x 18.2 x 14.9 x 13.1 x
Yield 0.31% 0.54% 0.88% 1.65% 1.99% 2.29%
Capitalization / Revenue 20.2 x 12.6 x 5.23 x 2.82 x 2.41 x 2.14 x
EV / Revenue 19.8 x 12.1 x 4.88 x 2.49 x 2.07 x 1.76 x
EV / EBITDA 75.7 x 47.7 x 27.3 x 12.6 x 10 x 9.13 x
EV / FCF 90.1 x 146 x 79.4 x 14.7 x 12.5 x 11 x
FCF Yield 1.11% 0.68% 1.26% 6.79% 8.03% 9.08%
Price to Book 17.1 x 11.4 x 4.93 x 2.96 x 2.57 x 2.23 x
Nbr of stocks (in thousands) 423,600 423,600 423,600 420,605 - -
Reference price 2 192.3 149.2 68.17 46.88 46.88 46.88
Announcement Date 22-03-22 23-03-29 24-04-25 - - -
1CNY in Million2CNY
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2021 2022 2023 2024 2025 2026
Net sales 1 4,022 5,014 5,522 6,992 8,191 9,207
EBITDA 1 1,050 1,273 985.9 1,385 1,689 1,779
EBIT 1 1,016 1,212 878 1,201 1,486 1,637
Operating Margin 25.25% 24.18% 15.9% 17.17% 18.14% 17.78%
Earnings before Tax (EBT) 1 1,018 1,214 868.8 1,277 1,540 1,710
Net income 1 862.9 1,051 756.8 1,114 1,358 1,526
Net margin 21.45% 20.97% 13.7% 15.94% 16.58% 16.58%
EPS 2 2.120 2.480 1.790 2.575 3.141 3.586
Free Cash Flow 1 882.3 416 339.1 1,182 1,360 1,474
FCF margin 21.93% 8.3% 6.14% 16.91% 16.61% 16%
FCF Conversion (EBITDA) 84.01% 32.68% 34.39% 85.36% 80.54% 82.83%
FCF Conversion (Net income) 102.24% 39.58% 44.8% 106.07% 100.17% 96.54%
Dividend per Share 2 0.6000 0.8000 0.6000 0.7726 0.9348 1.074
Announcement Date 22-03-22 23-03-29 24-04-25 - - -
1CNY in Million2CNY
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2021 Q4 2022 Q1 2022 Q2 2022 S1 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 S1 2023 Q3 2023 Q4 2023 S2 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1 2025 Q2
Net sales 1 1,910 808.5 1,241 2,050 845.8 2,118 863.3 1,504 2,368 1,064 2,091 3,154 - 1,811 1,274 2,843 1,297 2,260
EBITDA 1 - - 213.3 - - - - - - - - - - 384 - - - -
EBIT 1 594.7 175.6 291.3 466.9 132.6 612.6 180.2 317.2 - 139 241.6 380.5 - 293.1 131.1 466.2 - -
Operating Margin 31.14% 21.72% 23.47% 22.78% 15.68% 28.92% 20.87% 21.09% - 13.07% 11.55% 12.06% - 16.18% 10.29% 16.4% - -
Earnings before Tax (EBT) 1 - - - - 133 614 - 338.7 512.7 137.8 240 - - 301.8 125.9 538.8 - -
Net income 1 - - 249.1 395 122.3 533.9 - 291.7 450 129.2 177.6 306.8 - 251.1 99.63 461.8 - -
Net margin - - 20.07% 19.27% 14.46% 25.2% - 19.39% 19.01% 12.14% 8.5% 9.73% - 13.86% 7.82% 16.24% - -
EPS 2 - - 0.5900 - 0.2900 1.260 - 0.6900 - 0.3000 0.4300 - - 0.5928 0.2352 1.090 - -
Dividend per Share 2 - - - - - - - - - - - - - 0.7788 - - - 0.8525
Announcement Date 22-03-22 22-04-27 22-08-28 22-08-28 22-10-25 23-03-29 23-04-26 23-08-28 23-08-28 23-10-29 24-04-25 24-04-25 24-04-25 - - - - -
1CNY in Million2CNY
Estimates

Balance Sheet Analysis

Fiscal Period: December 2021 2022 2023 2024 2025 2026
Net Debt 1 - - - - - -
Net Cash position 1 1,986 2,452 1,941 2,319 2,779 3,485
Leverage (Debt/EBITDA) - - - - - -
Free Cash Flow 1 882 416 339 1,182 1,360 1,474
ROE (net income / shareholders' equity) 29% 20.5% 13.2% 16.5% 17.7% 17.2%
ROA (Net income/ Total Assets) 23.3% 16.8% 10.6% 13.6% 14.7% 15%
Assets 1 3,707 6,266 7,113 8,173 9,262 10,179
Book Value Per Share 2 11.20 13.10 13.80 15.80 18.20 21.00
Cash Flow per Share 2 2.830 1.820 1.440 2.860 3.080 3.830
Capex 1 270 353 271 274 269 241
Capex / Sales 6.72% 7.05% 4.91% 3.93% 3.28% 2.62%
Announcement Date 22-03-22 23-03-29 24-04-25 - - -
1CNY in Million2CNY
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
22
Last Close Price
46.88 CNY
Average target price
74.64 CNY
Spread / Average Target
+59.21%
Consensus
  1. Stock Market
  2. Equities
  3. 300957 Stock
  4. Financials Yunnan Botanee Bio-Technology Group Co.LTD